Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]
This document describes an early-phase, first-in-human safety and immunogenicity study of the vaccine candidates SCB-1022 and SCB-1033 in he…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults [Phase 3]
A Phase 3 clinical trial is evaluating the immunogenicity and safety of the mRNA-1345 RSV vaccine in high-risk adults. The trial status is a…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) [Phase 1, Phase 2]
This clinical trial update reports on Phase 1/2 studies testing two doses of PRS CK STORM to calm cytokine storms in ARDS caused by SARS-CoV…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Pfizer completed a Phase 2 trial evaluating multiple doses of sisunatovir in individuals with respiratory syncytial virus infection. The upd…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults [Phase 1]
Phase 1 study evaluating the effect of Zelicapavir (EDP-938) on the QTc interval in healthy adults, with RSV infection listed as a condition…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection [Phase 2]
A Phase 2 study evaluating Obeldesivir for treating RSV infection in nonhospitalized adults was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV [Phase 2]
A Phase 2 clinical trial evaluating Deuremidevir Hydrobromide for Suspension in Chinese infants hospitalized with Respiratory Syncytial Viru…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
This clinical trial in Japan investigates how respiratory virus infections affect emergency admissions, focusing on Respiratory Syncytial Vi…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
A clinical trial registry entry describing a surveillance study of respiratory syncytial virus (RSV) in acute respiratory infections among c…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above [Phase 2]
Phase 2 study evaluating immune response and safety of an RSV vaccine in adults 18 and older who received lung or kidney transplants and are…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants [Phase 3]
A Phase 3 clinical trial evaluating the RSVpreF vaccine in pregnant participants with HIV and their infants has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus [Phase 2]
Phase 2 clinical trial of Moderna's RSV vaccine mRNA-1345 in children aged 2 to under 18 at high risk has been completed.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Study to Evaluate EDP 938 Regimens in Children With RSV [Phase 2]
A Phase 2 study evaluating regimens of the RSV antiviral EDP-938 in children has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Assessing Antiviral Treatments in Early Symptomatic RSV [Phase 2]
Phase 2 clinical trial led by the University of Oxford is evaluating antiviral treatments for early symptomatic respiratory syncytial virus …
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. [Phase 1]
This Phase 1 drug-drug interaction study evaluated how itraconazole, carbamazepine, quinidine, and fluconazole affect the pharmacokinetics a…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. [Phase 2]
The Phase 2 study of EDP-938 for respiratory syncytial virus infection in high-risk, non-hospitalized adults has completed.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. [Phase 3]
Phase 3 international adaptive platform trial in Europe evaluating two RSV prevention options—maternal vaccine during pregnancy and an infan…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
This clinical trial update reports the completion of a study evaluating Labcorp's home collection kit for simultaneous testing of COVID-19, …
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
A Phase 2 study evaluating Obeldesivir for treating RSV infection in children was terminated.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
A clinical trial in France is recruiting infants to evaluate prevention strategies for Respiratory Syncytial Virus (RSV) infections. The stu…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Assessing the Burden of Respiratory Syncytial Virus (RSV)
A clinical trial sponsored by Abu Dhabi Health Services Company is assessing the burden of Respiratory syncytial virus infection and related…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA
Clinical trial enrolling to surveil, assess, and detect influenza-associated respiratory infections in HIV-positive and HIV-negative individ…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years [Phase 1]
Phase I first-in-human study evaluating safety and tolerability of EuRSV in healthy adults aged 19–80. The trial status is active but not re…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of a recombinant RSV vaccine produced in CHO cells in healthy adults aged …
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults [Phase 1]
A first-in-human Phase 1 study evaluating the safety and immunogenicity of RSV vaccine candidates SCB-1019 and SCB-1019T in healthy adults h…